The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.
about
Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsHigh dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona.HIV-associated neurocognitive disorder.Spontaneous strategy use protects against visual working memory deficits in older adults infected with HIVCombination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVThe antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia.The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells.Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders.Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease.The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.
P2860
Q33614467-B0F97D68-FFD5-4A98-8878-EB050FA1677FQ33919019-34907480-841C-4BED-8A69-F306972B1801Q33939729-8DEC4467-EE0A-40BB-9DD1-ABE8EA3C6EC0Q34302250-77DB04B1-42DA-45E2-ACCF-2FD9B193E07EQ34714277-6195A394-FFA0-478E-9D96-FF2C190BF9BDQ35526694-EAEABD85-A065-479B-A226-AE384846AED7Q36086462-382A5921-08C7-40C5-A43B-FEAB7ECC6594Q36676803-8E6FEE31-40B4-4E2B-A052-720522909640Q36889342-8550BEE9-4A4A-4A3E-BDBD-831BAF6974C1Q37073677-0C2E068F-61F9-424B-B804-6E1DB30871DAQ40738275-64852435-2132-4227-9E85-6C10DA56A5C4Q40856889-F7454C5E-E664-4F7D-8129-2BE4C5DE8111Q41950909-5D0433BA-CAD5-4BF4-88D2-CCD612BBF2CDQ45326481-8B47252C-700B-47DB-8A49-730A3A517B74
P2860
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The role of cohort studies in ...... in the central nervous system.
@en
The role of cohort studies in ...... in the central nervous system.
@nl
type
label
The role of cohort studies in ...... in the central nervous system.
@en
The role of cohort studies in ...... in the central nervous system.
@nl
prefLabel
The role of cohort studies in ...... in the central nervous system.
@en
The role of cohort studies in ...... in the central nervous system.
@nl
P2093
P2860
P50
P1476
The role of cohort studies in ...... in the central nervous system.
@en
P2093
Ann C Collier
Benjamin B Gelman
Brookie Best
Christina Marra
David B Clifford
David Simpson
J Allen McCutchan
Janis Durelle
Jennifer Marquie-Beck
Justin C McArthur
P2860
P2888
P304
P356
10.1007/S11481-006-9054-Y
P577
2007-01-03T00:00:00Z